Zhejiang Xianju Pharmaceutical Co Ltd Cash Flow Conversion Efficiency
Zhejiang Xianju Pharmaceutical Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Zhejiang Xianju Pharmaceutical Co Ltd (002332) has a cash flow conversion efficiency ratio of 0.022x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥130.05 Million ≈ $19.03 Million USD) by net assets (CN¥6.03 Billion ≈ $881.71 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Zhejiang Xianju Pharmaceutical Co Ltd (2006–2025)
Cash flow conversion efficiency of Zhejiang Xianju Pharmaceutical Co Ltd from 2006 to 2025. This chart illustrates how Zhejiang Xianju Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 002332 live share price for real-time trading data and today's change.
Zhejiang Xianju Pharmaceutical Co Ltd Cash Flow Conversion Ratio Explained
Zhejiang Xianju Pharmaceutical Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Zhejiang Xianju Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zhejiang Xianju Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Also see 002332 market cap overview for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Upwork Inc
NASDAQ:UPWK
|
0.101x |
|
Altus Group Limited
TO:AIF
|
0.004x |
|
Shenzhen Rongda Photosensitive & Technology Co Ltd
SHE:300576
|
0.034x |
|
Centuria Industrial REIT
AU:CIP
|
0.018x |
|
Jilin OLED Material Tech Co Ltd
SHG:688378
|
-0.012x |
|
Lotte Rental Co Ltd
KO:089860
|
-0.077x |
|
Shanghai Weaver Network Co Ltd
SHG:603039
|
0.046x |
|
Kailera Therapeutics, Inc. Common Stock
NASDAQ:KLRA
|
-0.069x |
Annual Cash Flow Conversion Efficiency for Zhejiang Xianju Pharmaceutical Co Ltd (2006–2025)
The table below shows the annual cash flow conversion efficiency of Zhejiang Xianju Pharmaceutical Co Ltd from 2006 to 2025. Review 002332 cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥6.08 Billion ≈ $890.00 Million |
CN¥247.48 Million ≈ $36.21 Million |
0.041x | -39.90% |
| 2024-12-31 | CN¥5.89 Billion ≈ $861.62 Million |
CN¥398.66 Million ≈ $58.34 Million |
0.068x | -33.71% |
| 2023-12-31 | CN¥5.83 Billion ≈ $853.12 Million |
CN¥595.48 Million ≈ $87.14 Million |
0.102x | -7.67% |
| 2022-12-31 | CN¥5.51 Billion ≈ $805.91 Million |
CN¥609.28 Million ≈ $89.16 Million |
0.111x | -19.09% |
| 2021-12-31 | CN¥4.94 Billion ≈ $723.59 Million |
CN¥676.15 Million ≈ $98.94 Million |
0.137x | -20.61% |
| 2020-12-31 | CN¥4.58 Billion ≈ $670.54 Million |
CN¥789.23 Million ≈ $115.49 Million |
0.172x | +1.34% |
| 2019-12-31 | CN¥3.06 Billion ≈ $447.57 Million |
CN¥519.81 Million ≈ $76.06 Million |
0.170x | +138.33% |
| 2018-12-31 | CN¥2.71 Billion ≈ $396.60 Million |
CN¥193.27 Million ≈ $28.28 Million |
0.071x | +1.60% |
| 2017-12-31 | CN¥2.39 Billion ≈ $349.14 Million |
CN¥167.47 Million ≈ $24.51 Million |
0.070x | +0.71% |
| 2016-12-31 | CN¥2.24 Billion ≈ $327.35 Million |
CN¥155.91 Million ≈ $22.81 Million |
0.070x | -24.84% |
| 2015-12-31 | CN¥2.15 Billion ≈ $314.98 Million |
CN¥199.61 Million ≈ $29.21 Million |
0.093x | -19.61% |
| 2014-12-31 | CN¥1.23 Billion ≈ $179.69 Million |
CN¥141.64 Million ≈ $20.73 Million |
0.115x | +114.84% |
| 2013-12-31 | CN¥1.18 Billion ≈ $172.97 Million |
CN¥63.46 Million ≈ $9.29 Million |
0.054x | +93.15% |
| 2012-12-31 | CN¥1.20 Billion ≈ $175.98 Million |
CN¥33.43 Million ≈ $4.89 Million |
0.028x | -78.28% |
| 2011-12-31 | CN¥1.15 Billion ≈ $168.80 Million |
CN¥147.63 Million ≈ $21.60 Million |
0.128x | -7.59% |
| 2010-12-31 | CN¥1.12 Billion ≈ $164.09 Million |
CN¥155.29 Million ≈ $22.72 Million |
0.138x | +45.55% |
| 2009-12-31 | CN¥1.10 Billion ≈ $160.99 Million |
CN¥104.68 Million ≈ $15.32 Million |
0.095x | +7.10% |
| 2008-12-31 | CN¥405.55 Million ≈ $59.34 Million |
CN¥36.03 Million ≈ $5.27 Million |
0.089x | -63.11% |
| 2007-12-31 | CN¥400.83 Million ≈ $58.65 Million |
CN¥96.53 Million ≈ $14.13 Million |
0.241x | +77.49% |
| 2006-12-31 | CN¥390.97 Million ≈ $57.21 Million |
CN¥53.05 Million ≈ $7.76 Million |
0.136x | -- |
About Zhejiang Xianju Pharmaceutical Co Ltd
Zhejiang Xianju Pharmaceutical Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of steroid raw materials and preparations in China and internationally. The company offers gynecological, anesthesia, respiratory, dermatology, generic drug, and other products; active pharmaceutical ingredients (API), such as corticosteroids, sex hormone, progestero… Read more